Remove 2021 Remove Access Remove Conditions Remove Treatment
article thumbnail

Missouri Republican,Michael Davis, proposes adding access to LSD, MDMA, peyote, and psilocybin as treatment options

Cannabis Law Report

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

article thumbnail

Which States Offer Medical Cannabis For Mental Health Conditions?

Veriheal

According to the 2021 State of Mental Health in America by nonprofit organization Mental Health America (MHA), 19% of adults experienced a mental illness between 2017 and 2018, an increase of 1.5 One of the major obstacles many with a mental illness face is access to and affordability of treatment and resources. Anorexia, PTSD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ryan’s Law Will Increase Terminally Ill CA Patients’ Access to Cannabis

Veriheal

Gavin Newsom signed a bill known as Ryan’s Law requiring hospitals in the state to allow terminally ill patients access to medical cannabis for treatment and pain relief. hospitals currently prohibit the ingestion of cannabis on-site regardless of the treatment it can provide for patients—particularly those in hospice.

Access 117
article thumbnail

Sapphire Medical Clinics expands patient access to cheapest medical cannabis fees in UK

Cannabis Law Report

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52
article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

article thumbnail

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. 30 September 2021. On 5 August 2021, the TGA announced that an Independent Expert Panel had been established to undertake the review. Summary of the Panel Report. URL: [link].

article thumbnail

Texas Is Attempting to Combat Its Opioid Crisis With Medical Cannabis

Veriheal

In 2015, Texas passed the Compassionate Use Act, which allowed patients with intractable epilepsy to access low-THC cannabis oil containing no more than 0.5% In 2019, the program was expanded to include patients with other qualifying conditions, such as terminal cancer, autism, multiple sclerosis, and certain neurological disorders.

Programs 102